Cargando…

RAS Blockade for Every Diabetic Patient: Pro and Con

Detalles Bibliográficos
Autores principales: Ruilope, Luis M., Solini, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632200/
https://www.ncbi.nlm.nih.gov/pubmed/21525476
http://dx.doi.org/10.2337/dc11-s248
_version_ 1782266859866816512
author Ruilope, Luis M.
Solini, Anna
author_facet Ruilope, Luis M.
Solini, Anna
author_sort Ruilope, Luis M.
collection PubMed
description
format Online
Article
Text
id pubmed-3632200
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-36322002013-07-15 RAS Blockade for Every Diabetic Patient: Pro and Con Ruilope, Luis M. Solini, Anna Diabetes Care Hypertension American Diabetes Association 2011-05 2011-04-22 /pmc/articles/PMC3632200/ /pubmed/21525476 http://dx.doi.org/10.2337/dc11-s248 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Hypertension
Ruilope, Luis M.
Solini, Anna
RAS Blockade for Every Diabetic Patient: Pro and Con
title RAS Blockade for Every Diabetic Patient: Pro and Con
title_full RAS Blockade for Every Diabetic Patient: Pro and Con
title_fullStr RAS Blockade for Every Diabetic Patient: Pro and Con
title_full_unstemmed RAS Blockade for Every Diabetic Patient: Pro and Con
title_short RAS Blockade for Every Diabetic Patient: Pro and Con
title_sort ras blockade for every diabetic patient: pro and con
topic Hypertension
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632200/
https://www.ncbi.nlm.nih.gov/pubmed/21525476
http://dx.doi.org/10.2337/dc11-s248
work_keys_str_mv AT ruilopeluism rasblockadeforeverydiabeticpatientproandcon
AT solinianna rasblockadeforeverydiabeticpatientproandcon